NCT02047084
Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
Enrolling by Invitation
Not specifiedAges 21–90ObservationalSolsys Medical LLC
~50 participants
Updated 2023-11-29 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Wound Closure outcome using one of two cohorts that has be randomly selected
Measured over Wound healing outcome will be evaluated at 12 weeks
Conditions
Where it's being run
1 sites across 1 statesSouth Carolina1
Study leadership
- Michael A. Towler, MD · PRINCIPAL_INVESTIGATOR · St. Francis Wound Care Center
- Arnold R Landsman, DPM · STUDY_DIRECTOR · Soluble Systems
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Wound Closure outcome using one of two cohorts that has be randomly selectedWound healing outcome will be evaluated at 12 weeks
The study treatment will be administered and the patient will be followed until the study ulcer has completely healed (i.e., 100% closure as determined by the Investigator, for up to 12 weeks. During the Treatment Phase subjects will be evaluated on a weekly basis. Efficacy evaluations each week will include Investigator assessment of wound closure and evaluations of ulcer size.